Annual Shareholders Equity
$263.10 M
-$50.53 M-16.11%
December 31, 2024
Summary
- As of March 5, 2025, TNDM annual stockholders equity is $263.10 million, with the most recent change of -$50.53 million (-16.11%) on December 31, 2024.
- During the last 3 years, TNDM annual shareholders equity has fallen by -$170.01 million (-39.25%).
- TNDM annual shareholders equity is now -40.20% below its all-time high of $439.95 million, reached on December 31, 2022.
Performance
TNDM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$263.10 M
+$25.39 M+10.68%
December 31, 2024
Summary
- As of March 5, 2025, TNDM quarterly stockholders equity is $263.10 million, with the most recent change of +$25.39 million (+10.68%) on December 31, 2024.
- Over the past year, TNDM quarterly shareholders equity has dropped by -$50.53 million (-16.11%).
- TNDM quarterly shareholders equity is now -41.48% below its all-time high of $449.58 million, reached on June 30, 2022.
Performance
TNDM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TNDM Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.1% | -16.1% |
| 3 y3 years | -39.3% | -40.2% |
| 5 y5 years | +34.9% | -40.2% |
TNDM Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.2% | at low | -41.5% | +12.5% |
| 5 y | 5-year | -40.2% | +34.9% | -41.5% | +34.9% |
| alltime | all time | -40.2% | +348.1% | -41.5% | +283.4% |
Tandem Diabetes Care Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $263.10 M(-16.1%) | $263.10 M(+10.7%) |
| Sep 2024 | - | $237.71 M(+1.6%) |
| Jun 2024 | - | $233.88 M(-3.8%) |
| Mar 2024 | - | $243.06 M(-22.5%) |
| Dec 2023 | $313.63 M(-28.7%) | $313.63 M(-0.1%) |
| Sep 2023 | - | $314.00 M(-4.6%) |
| Jun 2023 | - | $329.23 M(-2.8%) |
| Mar 2023 | - | $338.75 M(-23.0%) |
| Dec 2022 | $439.95 M(+1.6%) | $439.95 M(+4.3%) |
| Sep 2022 | - | $421.82 M(-6.2%) |
| Jun 2022 | - | $449.58 M(+2.8%) |
| Mar 2022 | - | $437.38 M(+1.0%) |
| Dec 2021 | $433.11 M(+18.2%) | $433.11 M(+11.2%) |
| Sep 2021 | - | $389.65 M(+12.6%) |
| Jun 2021 | - | $346.08 M(+10.4%) |
| Mar 2021 | - | $313.41 M(-14.4%) |
| Dec 2020 | $366.31 M(+87.9%) | $366.31 M(+12.2%) |
| Sep 2020 | - | $326.54 M(+22.0%) |
| Jun 2020 | - | $267.70 M(+29.2%) |
| Mar 2020 | - | $207.18 M(+6.3%) |
| Dec 2019 | $194.98 M(+48.5%) | $194.98 M(+16.8%) |
| Sep 2019 | - | $166.99 M(+14.9%) |
| Jun 2019 | - | $145.34 M(+20.2%) |
| Mar 2019 | - | $120.96 M(-7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $131.28 M(-550.4%) | $131.28 M(+13.7%) |
| Sep 2018 | - | $115.43 M(+343.9%) |
| Jun 2018 | - | $26.00 M(+119.5%) |
| Mar 2018 | - | $11.85 M(-140.6%) |
| Dec 2017 | -$29.15 M(+391.8%) | -$29.15 M(+4.3%) |
| Sep 2017 | - | -$27.96 M(+53.0%) |
| Jun 2017 | - | -$18.28 M(+878.5%) |
| Mar 2017 | - | -$1.87 M(-68.5%) |
| Dec 2016 | -$5.93 M(-109.3%) | -$5.93 M(-214.0%) |
| Sep 2016 | - | $5.20 M(-83.8%) |
| Jun 2016 | - | $32.07 M(-30.2%) |
| Mar 2016 | - | $45.94 M(-27.6%) |
| Dec 2015 | $63.47 M(+16.3%) | $63.47 M(-10.9%) |
| Sep 2015 | - | $71.23 M(-18.8%) |
| Jun 2015 | - | $87.75 M(-14.2%) |
| Mar 2015 | - | $102.25 M(+87.4%) |
| Dec 2014 | $54.57 M(-52.8%) | $54.57 M(-19.1%) |
| Sep 2014 | - | $67.48 M(-19.2%) |
| Jun 2014 | - | $83.55 M(-14.1%) |
| Mar 2014 | - | $97.26 M(-15.8%) |
| Dec 2013 | $115.54 M(-208.9%) | $115.54 M(-180.5%) |
| Sep 2013 | - | -$143.44 M(+9.1%) |
| Jun 2013 | - | -$131.49 M(+24.0%) |
| Dec 2012 | -$106.05 M(+48.8%) | -$106.05 M |
| Dec 2011 | -$71.29 M | - |
FAQ
- What is Tandem Diabetes Care annual stockholders equity?
- What is the all time high annual shareholders equity for Tandem Diabetes Care?
- What is Tandem Diabetes Care annual shareholders equity year-on-year change?
- What is Tandem Diabetes Care quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Tandem Diabetes Care?
- What is Tandem Diabetes Care quarterly shareholders equity year-on-year change?
What is Tandem Diabetes Care annual stockholders equity?
The current annual shareholders equity of TNDM is $263.10 M
What is the all time high annual shareholders equity for Tandem Diabetes Care?
Tandem Diabetes Care all-time high annual stockholders equity is $439.95 M
What is Tandem Diabetes Care annual shareholders equity year-on-year change?
Over the past year, TNDM annual stockholders equity has changed by -$50.53 M (-16.11%)
What is Tandem Diabetes Care quarterly stockholders equity?
The current quarterly shareholders equity of TNDM is $263.10 M
What is the all time high quarterly shareholders equity for Tandem Diabetes Care?
Tandem Diabetes Care all-time high quarterly stockholders equity is $449.58 M
What is Tandem Diabetes Care quarterly shareholders equity year-on-year change?
Over the past year, TNDM quarterly stockholders equity has changed by -$50.53 M (-16.11%)